Cited by 362Heart Failure Treatment and ManagementCardiac pacing and defibrillation studiesCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 250 of the 255 references it cites were found in a registry or an index.

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Open access

Maddox, Thomas M., Januzzi, James L., Allen, Larry A., Breathett, Khadijah, Brouse, Sara, Butler, Javed, Davis, Leslie L., Fonarow, Gregg C., Ibrahim, Nasrien E., Lindenfeld, JoAnn, Masoudi, Frederick A., Motiwala, Shweta R., Oliveros, Estefania, Walsh, Mary Norine, Wasserman, Alan, Yancy, Clyde W., Youmans, Quentin R.·2024·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2023.12.024

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2023.12.024

Cites

250 of 250 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citation
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Human agency in social cognitive theory.
Bandura, A. (1989) · American Psychologist · doi:10.1037/0003-066x.44.9.1175 · Cited by 8,263
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382

Flagged first, then by citations

Show all 255 references

5 of the 255 references couldn’t be matched to a known paper.

Research works printed but not linked: 12

Desai, 2019, Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial, JAMA, 1
Mann, 2020, Sacubitril/valsartan in advanced heart failure with reduced ejection fraction: rationale and design of the LIFE Trial, J Am Coll Cardiol HF, 8, 789
Solomon, 2020, Effect of dapagliflozin in patients with hfref treated with sacubitril/valsartan: the DAPA-HF Trial, J Am Coll Cardiol HF, 8, 811
DeFilippis, 2020, Considerations for heart failure during the COVID-19 pandemic, J Am Coll Cardiol HF, 8, 681
Daubert, 2019, NT-proBNP goal achievement is associated with significant reverse remodelings and improved clinical outcomes in HFrEF, J Am Coll Cardiol HF, 7, 158
Myhre, 2022, Early B-Type natriuretic peptide change in HFrEF patients treated with sacubitril/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF, J Am Coll Cardiol HF, 10, 119
McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
Vaduganathan, 2020, Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: The CHAMP-HF Registry, J Am Coll Cardiol HF, 8, 469
Berardi, 2020, Angiotensin-neprilysin inhibition in Black Americans: data from the PIONEER-HF Trial, J Am Coll Cardiol HF, 8, 859
Pandey, 2019, Frailty is interwined with heart failure: mechanisms, prevalence, prognosis, assessment and management, J Am Coll Cardiol HF, 7, 1001
Mozaffarian, 2016, Heart disease and stroke statistic - 2016 update: a report from the American Heart Association, Circulation, 133, e38
2023, Standards of Medical Care in Diabetes-2024, Diabetes Care, 47, Suppl 1

Sorted by citations

Items 201–300 of 325

Asistencia circulatoria mecánica en falla cardíaca avanzada: definiciones, avances y desafíos actuales
Velásquez-Silva, C., & Rojas, S. V. (2025) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2025.10.001
Association of borderline pulmonary artery wedge pressure with major cardiovascular events in patients with pulmonary hypertension and chronic kidney disease
Manzano, J. M. M., Lopez, E. K., Geller, A., Wattanachayakul, P., Malin, J. H., LEGUIZAMON, R., John, T. A., Ricaurte, M. V., Jarrett, S. A., Lo, K. B., et al. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.11.003
Beyond Diursesis: Rethinking Fluid and Sodium Strategies in Heart Failure.
Arun, A., Baig, M., Darji, B., & Frishman, W. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001088
A Pathophysiologic Mechanism for the Treatment of Salt-Sensitive Hypertension and Heart Failure: The Role of β-Arrestins
Chrysant, S. G. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01495-y
Chronic Heart Failure in the Pediatric Population
Hussain, S. F., Ikeda, N., & Ryan, T. D. (2025) · Springer eBooks · doi:10.1007/978-1-4471-4999-6_274-1
Heart Failure Treatment—The Last Pieces of the Puzzle
Ioniţă, O., & Dorobantu, L. F. (2025) · Springer eBooks · doi:10.1007/978-3-031-96562-3_18
Guideline-Based Elevated NT-proBNP Among Asymptomatic Adults with Diabetes in Saudi Arabia: Prevalence and Real-World Clinical Correlates
Hayek, A. A., Borai, A., AlHabeeb, W., Zahrani, W. M. A., Mashali, M. A., & Dawish, M. A. A. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03463-6
Relation Between Neutrophil Count and Left Ventricular Ejection Fraction Following Acute Myocarditis in Adolescents: A Preliminary Study
Rabiega, B., Wysocka, D., Urbanowicz, T. K., Olasińska‐Wiśniewska, A., Jemielity, M., & Bobkowski, W. (2025) · Children · doi:10.3390/children13010040
Heart Failure Assessment
Koshman, S. L. (2025) · Springer eBooks · doi:10.1007/978-3-032-10050-4_16
Case Report: A case of heart failure recovery after non-ischemic cardiomyopathy following chimeric antigen receptor T-cell therapy
Spears, G. S., Henson, J. C., Vellanki, S., Trikannad, A., & Paydak, H. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1608404
Sodium-glucose transporter inhibitors 2 in acutely ill patients
Zampieri, F. G., Meersch, M., & See, E. J. (2026) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001194
Durable Remission After Triple Therapy in New-Onset HFrEF
Pitonak, M., Munch, J., Thibodeau, J. T., & Drazner, M. H. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2025.106526
A Preliminary Exploration of Congestion Score in Heart Failure via Unsupervised Machine Learning
Chao, H.-Y., Yang, C.-C., Chiang, Y.-Y., Kuo, Y.-H., Shih, Y.-H., Chiu, L.-J., Chen, H., & Lee, G. G. C. (2025) · International Conference on Artificial Intelligence for Medicine, Health and Care (AIxMHC) · doi:10.1109/aixmhc65380.2025.00040
Immune checkpoint inhibition and heart injury: molecular mechanisms and clinical challenges
Lv, S., Xu, J., Yang, L., Cui, J., Xin, Y., Zhao, Y., Li, P., Han, H., Li, J., & Liu, A. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvaf015
Vericiguat in Routine Practice: Insights from a Prospective Real-World Study in Chinese Population
Binaghi, G., & Amodeo, J. (2026) · Cardiology · doi:10.1159/000549800
BRASH syndrome as a clinical syndrome driven by polypharmacy: a pharmacovigilance study of 1,081 cases from FAERSPreprint
Costantini, I., Breglia, A., Mantelli, G., Zanatta, M., & Ricci, G. (2026) · Research Square · doi:10.21203/rs.3.rs-8881897/v1
The Anaesthetist’s Point of View
Frigo, M. G., & Laffi, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-10702-2_15
Reperfusion therapy for older patients with acute myocardial infarction and cardiogenic shock
Kiyohara, Y., Minami, K., Freeman, L. M., Tang, W. H. W., Pinney, S., Yano, Y., Naito, T., & Miyashita, S. (2026) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2026.01.008
Cost‑effectiveness analysis of a specialized heart failure patient management system at the regional level
Nedogoda, S. V., Звартау, Н. Э., Solovyova, A. E., Вадимовна, В. С., Salasyuk, A. S., & Леонидовна, Б. С. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6643
Advances in the Management of Pediatric Heart Failure: From Medical Therapy to Mechanical Support and Transplantation
Ahmad, R., Kumar, M., Khan, S., Niaz, M., Frangaj, K., Arslan, F. S., Hussain, S. S., Maheta, D., Frishman, W. H., & Aronow, W. S. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001186
Forecasting left ventricular systolic dysfunction in heart failure with artificial intelligence
Bergamaschi, T. S., Yau, T., Chandak, P., Kyereme-Tuah, A., Hung, J. W., Gaggin, H. K., Kohane, I. S., & Stultz, C. M. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103783 · Cited by 1
Approach to Mitral Regurgitation in Advanced Heart Failure
Nguyen, L., & Shah, K. S. (2026) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.12.004
Insuficiencia cardíaca
Cubillo, Á. C. M., & Sánchez, C. G. (2026) · Actualización en Medicina de Familia · doi:10.55783/amf.220103
Early Initiation and Dose Optimization of Mineralocorticoid Receptor Antagonists in Heart Failure
Banerjee, S., Rajput, R., Shah, C. P., Raghunandan, B. K., Gupta, A., Chatterjee, S., Anne, K. P., Veer, A., Joshi, A., Raghuvanshi, A., et al. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1299
Tackling Therapeutic Inertia on Mineralocorticoid Receptor Antagonist Adoption in Heart Failure
Jaswal, A., Ghose, T., Aggarwal, A., Singh, A. K., Chakravarty, N., Roy, R., S, A. D., Patel, D. C., Sankhla, M., Anitha, M., et al. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1298
Guideline-directed medical therapy in older heart failure patients: survival gains, evidence gaps and the challenge of implementation
Si̇nan, Ü. Y. (2026) · Heart · doi:10.1136/heartjnl-2026-327799
Clinical and Economic Implications of Cardiac Resynchronization Timing and Longitudinal Medication Titration: A Real-world Medicare Analysis
Ekpo, E., Atwater, B. D., ZWEIBEL, S. L., Mignone, J., Lanctin, D., Mburu, W., & Heywood, J. T. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.02.031
Expert consensus on the application of angiotensin-converting enzyme inhibitors in the prevention and treatment of cardiovascular diseases
Cai, J., Li, Y., & Han, Y. (2026) · Cardiac Research · doi:10.1097/re9.0000000000000008
Discontinuation of Heart Failure Pharmacotherapy in Older Adults With Frailty
Nakamaru, R., Nishimura, S., Kumamaru, H., Daigo, K., Walsh, K., & Kohsaka, S. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047638
Second‐generation prokineticin PKR 1 receptor agonists: Advancing cardioprotection against chemotherapy‐induced toxicity
Audebrand, A., Brogi, S., Tezeren, M., Tafi, A., Ocak, O. H., Koyuncu, H., Tetko, I. V., Désaubry, L., & Nebigil, C. G. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70394
Prevalence and characterization of heart failure in Aragon, Spain (ICAR study)
Romero-Vigara, J. C., Lillo, J. I. G., Valero, D. B., Arbués-Espinosa, P., Luz-Miguel, S., Garcia-Solans, J. R., Bengoa-Urrengoechea, I., Natividad, S. L. D. L., González, M. S., González, E. S., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1749081
ANSWER-HF: sacubitril–valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling
Martins, E. B., Madrini, V., Souza, P. V. R., Tavares, C. A. M., Albuquerque, M. T. A., Santo, K., Harrington, J. A., Canonico, M. E., Rafei, A. E., Bonaca, M. P., et al. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10614-6
A Case of Heart Failure With Reduced Ejection Fraction Secondary to Dilated Cardiomyopathy due to Long‐Standing Untreated Acromegaly: A Case Report and Focused Literature Review
Bueno, C. O. P., Herrera-Leaño, N., Soto-Chávez, M. J., Parra, D., & Mariño, A. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72420
Practical Guideline-Directed Medical Therapy (PGDMT) in Heart Failure With Reduced and Mildly Reduced Ejection Fraction—Real World Multicenter Cross-sectional Interim Analysis at Enrollment: Data from Associates for Cardiology Education and Research Chronic Heart Failure (ACERT CHEF) Registry
Dorairaj, P., Uthirapathi, I., Karthikeyan, B., Janakiraman, E., Thiruvenkadam, P., Mohammed, S. B. K., Akber, S., Sengottuvelu, G., Natarajan, S., Sundar, R. H., et al. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.03.021
Stem cell therapy for heart failure: Distinct mechanisms and therapeutic implications in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction
Yue, Y.-X. (2025) · New cell · doi:10.61958/ncjf2750
Impact of Digital Remote Monitoring on the Optimization of Guideline-Directed Medical Therapy Titration in Heart Failure With Reduced Ejection Fraction
Kozhevnikova, M. V., Emelyanov, A. V., Анатольевна, Ж. Е., Pavlov, N. A., Khabarova, N. V., & Belenkov, Y. N. (2026) · Kardiologiia · doi:10.18087/cardio.2026.2.n3105
Lactation Safety in Peripartum Cardiomyopathy
Khalid, H., Kim, A. Y., Lau, T., Parikh, M. A., Ramasubbu, K., Frishman, W. H., & Peterson, S. J. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001258
Improving Heart Failure Discharge Care Through a Resident-Led Quality Improvement Initiative
Singtong, B., Chattha, S. S., Aboujaoude, C., Pathiranage, T. S., Farrukh, F., & Shah, P. A. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.107940
Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India
Pandey, B. P., Ray, S., Kumar, S., Guha, S., Desai, B., Shah, M., Kudva, S., Chopra, V., Agarwal, R., Rastogi, V., et al. (2026) · Cureus · doi:10.7759/cureus.107772
Calidad de vida en pacientes con insuficiencia cardiaca en Cartagena, Colombia: Estudio transversal comparativo
Leguia, L. A. S., Corpas, K. H., & Flórez-Torres, I. E. (2026) · Revista Ciencia y Cuidado · doi:10.22463/17949831.5494
Assessment of Peripheral Arterial (Normal) Flows in Multiple Vascular Territories in Patients Receiving Mechanical Cardiac Support
Natale, F., Loffredo, F. S., Caputo, A., Marra, C., Amarelli, C., Cimmino, G., & Golino, P. (2026) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_135_25
Effect of Handheld Echocardiography by Trained Advanced Practice Providers on Heart Failure Management and Readmissions
Tagle-Cornell, M. C., Novais, B. S., Wen, S., & Naqvi, T. Z. (2026) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2026.100720
Effect of bucladesine calcium combined with metoprolol on heart rate variability and cardiac function prognosis in heart failure patients with chronic arrhythmias
Sun, M., Fan, B., Lin, M., Yan, K., Yang, C., & Gao, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1740664
Joint latent profiles of death anxiety and treatment adherence in HCC patients
Sheng, S., Bai, L., Yundan, Z., Chen, H., ZhaXi, B., Duoji, L., Shu, Y., & Cao, X. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1792371
Medical Aid in Dying in New York: Clinical, Ethical, and Cardiovascular Considerations Under Assembly Bill A136
Branigan, P., & Duong, V. N. Y. (2026) · Cureus · doi:10.7759/cureus.108809
Análise do Perfil Clínico e Epidemiológico dos Pacientes com Insuficiência Cardíaca com Fração de Ejeção Reduzida em um Hospital do Sul Catarinense
Borges, G. A., Luca, M. D., & Bolan, A. C. (2026) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250027
Successful treatment of an apparently terminal stage of heart failure with anasarca resulting in achieved cardiac compensation: A case report
Nešović, P., Babić, S., Bastać, M., Joksimović, Z., & Bastać, D. (2026) · Timocki medicinski glasnik · doi:10.5937/tmg2601081n
Analysis of the Clinical and Epidemiological Profile of Patients with Heart Failure with Reduced Ejection Fraction in a Hospital in Southern Santa Catarina
Borges, G. A., Luca, M. D., & Bolan, A. C. (2025) · ABC Heart Fail Cardiomyop · doi:10.36660/abchf.20250027i
Posttraumatic Stress Symptoms in Patients on Ventricular Assist Device Support: Something to Worry About?
Kugler, C., Byrne, S., Spielmann, H., Richter, F., Semmig‐Könze, S., Spitz‐Köberich, C., Albert, W., Tigges‐Limmer, K., & the Selma Study Group (2026) · Clinical Transplantation · doi:10.1111/ctr.70556
Cost-effectiveness of catheter ablation in end-stage heart failure with atrial fibrillation: Insights from CASTLE-HTx
Boettger, P., Moersdorf, M., Sommer, P., Marrouche, N. F., Costard‐Jäckle, A., Crijns, H. J. G. M., Bergau, L., Fox, H., Hindricks, G., Dagres, N., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.05.024
Device-based therapies for cardiorenal syndrome: A comprehensive, mechanism-driven framework for next-generation decongestion
Giorgi, J. M., Chamay, S., Bacca, C. D. O. F., Dandamudi, M., de Lucena, L. A., Cavalcante, D. V. S., Samaniego-Laguna, M. A., Mojica, J., Batista, P. K. A., Barbagelata, A., et al. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106961
Combined Prognostic Value of Follow‐Up Ejection Fraction and Natriuretic Peptide Measurements in Heart Failure With Reduced Ejection Fraction Following Initiation of Pharmacotherapy
Kodur, N., Gunsalus, P. R., Milinovich, A., Dalton, J. E., & Tang, W. H. W. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047015
Temporary Left Ventricular Assist Devices
Balanescu, D. V., & Mankad, S. V. (2026) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2026.04.013
Impact of age on the prognostic benefit of follow-up in UMIPIC units: analysis of the RICA registry
Llàcer, P., Croset, F., Franco, Á. G., Cerqueiro, J. M., Mendez, M., Montero-Pérez-Barquero, M., Pérez-Silvestre, J., Conde, A., Dávila, M. F., Carrera, M., et al. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04371-5
Cluster of Differentiation 36-Mediated Inflammation and Lipid Metabolism in Cardiovascular Diseases: From Mechanisms to Novel Therapies
Song, J., Han, X., Zhang, Y., & Jiang, M. (2026) · Antioxidants · doi:10.3390/antiox15060694
How to Implement Recommendations on Multidisciplinary Heart Failure Management Program Into Practice? Lithuanian Experience
Čelutkienė, J., Lycholip, E., Burneikaitė, G., Kalakauskaitė, L., Karaliute, G., Kriukelytė, D., Barysienė, J., Zuozienė, G., Žaliaduonytė, D., Kavoliūnienė, A., et al. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.05.030
A Pragmatic Low-Cost Digital Support Pathway for GDMT Optimization in Ambulatory HFrEF: An Exploratory 6-Month Matched Cohort Study
Popovici, M., Kundnani, N. R., Păpurică, M., Dinu, A. R., Buciu, V., Bedreag, O. H., Sîrbu, E., Săndesc, D., & Dragan, S. R. (2026) · Healthcare · doi:10.3390/healthcare14121675
Research Progress in the Management of Peripartum Cardiomyopathy
张, 荣. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662296
The Art of Timing: Recognizing Signs and Symptoms of Advanced Heart Failure to Guide Timely Referral to Advanced Heart Failure Specialists
ElSaygh, J., Ahmed, M. M., Vilaro, J. R., Aranda, J. M., & Parker, A. M. (2026) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2026.0018
Challenges of heart failure treatment in patients with chronic kidney disease
Metry, M., & Bernard, S. (2026) · JAAPA · doi:10.1097/01.jaa.0000000000000375
Efficacy of a comprehensive medication management programme on medication adherence in patients with heart failure and polypharmacy (PERSEUS-HF): study protocol for a multicentre randomised controlled trial
Kagami, K., Kondo, T., Suzuki, S., Saito, Y., Fujiki, S., Takahashi, S., Iwano, H., Omote, K., Jujo, K., Nagatomo, Y., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-116761
Global Profiling of Protein Lysine Lactylation in Mouse Cardiac Hypertrophy: A Lactylome Analysis
Zhu, W., Guo, S., Yang, Y., Dong, Y., Liu, C., & Chen, C. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13070297
Hemodynamic evolution of heart failure from hypertension: lower stroke volume index and higher heart rate
Izzo, J. L., Srungavarapu, S. R., Khatri, C. P., Shalini, F., & Osmond, P. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag067
Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians
Fordan, S., Afridi, I., Garza, A., & Collazo-Maldonado, R. L. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2686460
Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now?
Memon, M., Qadeer, Y. K., Virk, H. U. H., Rizwan, A. M., Coomar, P. P., Alam, M., Khawaja, M., Rivera, M. R. R., Tang, W. H. W., & Krittanawong, C. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10646-y
Ironing Out the Details: Advancing Diagnosis and Treatment of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction – A Narrative Review
Gustafson, S. E., Patel, S. R., Fudim, M., Mentz, R. J., Sauer, A. J., Lala, A., Harrington, J., Pandey, A., Svetlichnaya, J., Fitzpatrick, J. K., et al. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10653-z
Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management
Ahmad, R., Ramchandani, J., Smith, D., Cheikhali, R., Weldehana, A., Goren, S., Jhang, C., Tao, J. M., Saribekyan, A., Frishman, W. H., et al. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001399
Heart Failure with Reduced and Mildly Reduced Ejection Fraction: A Network Interpretive Framework of Mechanisms, Phenotypes, and Therapeutic Response
Krasińska, B., Raffa, G. M., Pisano, C., Nuzzi, V., Manca, P., Filipiak, K. J., Rahnama, M., Kowalewski, M., Krasiński, Z., Suwalski, P., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146370 · Cited by 1
From Initiation of Guideline-Directed Medical Therapy to Persistent Use in Heart Failure—A Long Road Ahead
Spinler, S. A., Gale, S. E., & Kido, K. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2026.2875
Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations
Newsome, J. S. (2026) · Journal of Pharmacy Technology · doi:10.1177/87551225261466571
Renal resistance index reveals ‘driving effect’ of vericiguat for heart failure therapy: the possible way for guideline-directed medical therapy implementation?
Natale, F., Loffredo, F. S., D’Elia, S., Golino, P., & Cimmino, G. (2026) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001913
Comparative Effectiveness of Sacubitril/Valsartan Versus Sodium-Glucose Cotransporter 2 Inhibitors among Patients with Heart Failure with Reduced Ejection Fraction with or without Diabetes: A Cohort Study
Riaz, M., Smith, S. M., Winchester, D. E., Dietrich, E. A., & Park, H. (2026) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-026-00819-3
Real-World Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy: A Pharmacovigilance Study
Chai, G. W., Phi, Q., & Delgado, D. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13080349
In symptomatic HF, sacubitril–valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo
Steinberg, D. I. (2026) · Annals of Internal Medicine · doi:10.7326/annals-26-02647-jc
SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications
Neshat, N., Daneii, P., Neshat, S., Mojahedi, A., Frishman, W. H., & Aronow, W. S. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001420
Cardioprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors
Qi, L., Wright, E. M., & Cai, X. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103095
National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction
Keykhaei, M., Sandhu, A. T., Hsue, P. Y., Greene, S. J., Ziaeian, B., Kittleson, M. M., Villarreal-Gonzalez, M., Hallaj, S., Ramsis, M., Agarwal, M. A., et al. (2026) · JACC Heart Failure · doi:10.1016/j.jchf.2026.103295
Self-citation
Association between Anemia and Hematologic Traits at Hospital Discharge with One-Year Mortality Among Survivors of Critical IllnessPreprint
Marinho, L. L., Jeong, D., D’Angelo, M., Marshall, J. G., Russell, J. A., McQuilten, Z. K., Higgins, A. M., Ko, D. T., Haldenby, O., Fang, J., et al. (2026) · medRxiv · doi:10.64898/2026.08.03.26359579
Association of angiotensin receptor-neprilysin inhibitor duration with latent remodeling following implantable cardioverter defibrillator implantation
Lee, J., Oh, J., Kim, D., Yu, H. T., Lee, C. J., Kim, T.-H., Uhm, J., Kim, Y.-J., Pak, H., Joung, B., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.044
Estimating the Benefits of the Comprehensive Disease-modifying Pharmacological Treatment in Patients with Heart Failure
Escobar, C., Pérez, P. C., Rodríguez, J. M. F., Otero, I. G., Bahamonde, A. L., Cabeza, A. P., Pérez-Silvestre, J., Ràfols, C., García, J. S., & Esteban‐Fernández, A. (2026) · Cardiac failure review · doi:10.15420/cfr.2026.02
Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy
Tini, G., Perlati, I., Palma, S., Giovani, S., Santolamazza, C., Monda, E., Vagnarelli, F., Marini, M., Bertero, E., Michieli, L. D., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134721
Effectiveness Of HF-Care Educational Media on Self-Care Among Patients with Heart Failure: A Quasi-Experimental
Amalia, I. N., Ardianti, P. Y., Setiawan, D. R., & Daryaman, U. (2026) · Journal of Applied Nursing and Health · doi:10.55018/janh.v8i2.694
Managing Polypharmacy in Older Adults: A Practical Deprescribing Approach for Nurse Practitioners
Wade, M., Drew, C., & Efre, A. (2026) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2026.105964
Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights From the TREAT-AHF Registry
Varshney, A. S., Ambrosy, A. P., Furst, A., Zheng, J., Bhatt, A. S., Lala, A., Fonarow, G. C., Fudim, M., Greene, S. J., Collins, S. P., et al. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.07.022
Self-citation
Heart Failure
Chaparro, S. V., & Rivera-Rodríguez, M. (2026) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_192-2
Key advances in secondary prevention after coronary artery bypass grafting
Elsherbini, A., Patel, S. K., Fedak, L., & Verma, S. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001333
Shifting From Event Rates to Time at Home After Hospitalization for Heart Failure With Reduced Ejection Fraction: Trends and Equity in Days Alive and Out of Hospital in Singapore
Liu, S., Graves, N., Lee, S. Y. A., Lee, C. F., Senanayake, S. J., Chan, M. Y., Yeo, K. K., Hausenloy, D. J., & Kularatna, S. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.126.013579
Assessment of Adherence to Drug Therapy in Patients with Heart Failure Followed at a Specialized Outpatient Clinic
de Jesus, B. G. A. S., Oliveira, F. B., Meira, F. C. A., Oliveira, L. B., Costa, F., & Latado, A. L. (2026) · International Journal of Cardiovascular Sciences · doi:10.36660/ijcs.20250059
Abnormal “Escherichia Shigella-EAT-LAAD” axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitors
Jia-ming, H., Fang-yi, Z., Niu, X.-H., Hu, J.-F., Fan, S., Ying, Z., & Ma, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872678
Patterns of spironolactone management following hyperkalemia among hospitalized patients with heart failure and reduced ejection fraction: a retrospective single-center study
Alshammari, A., Bahamdain, F. O., Alshahrani, A. M., Kandasamy, G., Rabea, A. R. M., Alyamani, W., Idris, A., Kamfar, Y., Almalki, M., Alghamdi, S., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1870470
Social Drivers of Health Advisory
Breathett, K. K., Khavjou, O., Maddox, K. E. J., Knapp, S. M., Dowd, W. N., Aguayo, L., Echols, M. R., Hammond, G., Hayman, L. L., Kershaw, K. N., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103101
Self-citation
Therapies for Heart Failure: Clinical Updates and Perspectives
Iurciuc, S., Cozma, D. C., & Tudoran, C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176624
Defining Clinically Meaningful Within-Patient Changes in Heart Failure
Yehya, A., Hahn, R. T., Borlaug, B., Delgado, V., Ambrosy, A. P., Arena, R. A., Reza, N., Lewis, G. D., Tapaskar, N., Carbone, S., et al. (2026) · JACC Heart Failure · doi:10.1016/j.jchf.2026.103310
Self-citation
Pathological Mechanisms and Therapeutic Potential of Mitochondrial Dysfunction in Heart Failure
San, S., Yang, X., Shen, L., & Meng, K. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm51920
Cardiac Magnetic Resonance Findings and NT-proBNP in Heart Failure with Reduced Ejection Fraction
Memiş, K. B., Doğan, İ., Şahin, D., Gülmez, A. O., Özer, E., & Kantarcı, M. (2026) · Tomography · doi:10.3390/tomography12090128
Closing the Guideline-Directed Medical Therapy Loop in Heart Failure: A Framework for Accountable Digital Implementation (Preprint)Preprint
Wang, M.-H., Chen, Y.-T., Wu, H.-Y., Shih, P., Tsung-Neng, T., Li, W., & Wang, K.-Y. (2026) · doi:10.2196/preprints.111342
Racial Patterns in SGLT2 Inhibitor Prescribing by Care Signature pathway Use in HFrEF Hospitalizations
Kanaparthy, N. S., Possick, S. E., Rothenberg, C., Deborah, R., & Kim, N. (2026) · AJPM Focus · doi:10.1016/j.focus.2026.100558
Phenotypes and Pathways: Distinguishing Heart Failure in Women
Vicenty-Rivera, S. I., & Merced-Ortiz, F. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016900
Características clínico-epidemiológicas y manejo terapéutico de pacientes hospitalizados por insuficiencia cardíaca en el Hospital Nacional de Itauguá, 2024–2025
Herrera, C. D. C., Pérez, M. V. B., Orrego, A. A., Ros, L. L. R. D., & Aria, L. (2026) · Revista científica ciencias de la salud · doi:10.53732/rccsalud/e81140
Pregnancy-associated cardiac complications
Thordsen, S., & Arany, Z. P. (2026) · Med · doi:10.1016/j.medj.2026.101301

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K. K., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.022 · Cited by 872
Self-citation
2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554
Self-citation
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update
Hollenberg, S. M., Stevenson, L. W., Ahmad, T., Bozkurt, B., Butler, J., Davis, L. L., Drazner, M. H., Kirkpatrick, J. N., Morris, A. A., Page, R. L., II, et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.002 · Cited by 82
Self-citation
2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
Yancy, C. W., Januzzi, J. L., Allen, L. A., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Jessup, M. L., Lindenfeld, J., Maddox, T. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.025 · Cited by 284
Self-citation
Management of Heart Failure With Preserved Ejection Fraction: 2026 ACC Expert Consensus Decision Pathway
Kittleson, M. D., Panjrath, G. S., Bates, K., Breathett, K. K., Dixon, D. L., Januzzi, J. L., & Mohammed, S. F. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.018 · Cited by 15
Self-citation

See all

Authors: Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., Motiwala, S. R., Oliveros, E., Walsh, M. N., Wasserman, A., Yancy, C. W., & Youmans, Q. R.
ORCID: Maddox, Thomas M.
Januzzi, James L.
Allen, Larry A.
Breathett, Khadijah
Butler, Javed
Davis, Leslie L.
Fonarow, Gregg C.
Ibrahim, Nasrien E.
Lindenfeld, JoAnn
Masoudi, Frederick A.
Walsh, Mary Norine
Yancy, Clyde W.
Youmans, Quentin R.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2024-04
Volume: 83
Issue: 15
Pages: 1444-1488
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2023.12.024
OpenAlex: W4392581840
Cited by: 362
References: 255
Citations by year: 2026: 181 · 2025: 133 · 2024: 48
FWCI: 100.60
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 380 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: heart failure with reduced ejection fraction, expert consensus, heart failure treatment, guideline recommendations
MeSH terms: Cardiology, Cardiovascular System, Heart Failure, Humans, Stroke Volume, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks